Digital cameras are now commonly used to capture microscopic images of haematological cells. Thanks to technological advancements, the quality of such digital images can now rival that of those seen through a microscope. Haematological cells, such as leukocytes and red blood cells, are classified using digital images and software algorithms in digital imaging/morphology. For a subset of leukocytes, the digital system categorization agrees well with the gold standard, the manual microscope approach. As a result of digital imaging, doing a morphological examination of a peripheral blood smear is faster, more efficient, and more standardised. Other cell types, such as red blood cells and thrombocytes, could be analysed morphologically in the future, as well as digital examination of other materials, such as bone marrow samples. Manufacturers of digital microscopy equipment should conduct independent quality surveys to assure compliance with quality standards. Hematological cancers could be detected sooner and with more sensitivity and specificity if digital imaging and basic cell counter findings are combined.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Defining the clinical contribution of platelet-derived FXIII-A to regulation of fibrinolysis
Fahad S Alshehri, King Faisal Medical City for Southern Region, Saudi Arabia
Title : Multiple alloantibodies: The strategy for identifying antibodies and transfusion management
Ahmed Alharbi, King Abdulaziz Medical City, Saudi Arabia